Skip to main content
SpringerLink
Log in

Delays in generic atorvastatin leave patients out of pocket

  • Non-clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. now Sun Pharmaceuticals

References

  1. Luo J, et al. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending. JAMA Internal Medicine : 27 Jun 2016. Available from: URL: http://dx.doi.org/10.1001/jamainternmed.2016.3384

    Google Scholar 

  2. Gellad WF. Prescription of Brand-Name Medications When Generic Alternatives Are Available-Patently Unfair. JAMA Internal Medicine : 27 Jun 2016. Available from: URL: http://dx.doi.org/10.1001/jamainternmed.2016.3389

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Delays in generic atorvastatin leave patients out of pocket. PharmacoEcon Outcomes News 757, 11 (2016). https://doi.org/10.1007/s40274-016-3200-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3200-4

Search

Navigation